Small-Molecule Drug Discovery in Triple Negative Breast Cancer: Current Situation and Future Directions
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Small-Molecule Drug Discovery in Triple Negative Breast Cancer: Current Situation and Future Directions
Authors
Keywords
-
Journal
JOURNAL OF MEDICINAL CHEMISTRY
Volume 64, Issue 5, Pages 2382-2418
Publisher
American Chemical Society (ACS)
Online
2021-03-02
DOI
10.1021/acs.jmedchem.0c01180
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Metallointercalator [Ru(dppz)2(PIP)]2+ Renders BRCA Wild-Type Triple-Negative Breast Cancer Cells Hypersensitive to PARP Inhibition
- (2020) Nur Aininie Yusoh et al. ACS Chemical Biology
- FGFR3 signaling and function in triple negative breast cancer
- (2020) Nicole J. Chew et al. Cell Communication and Signaling
- Regorafenib sensitizes human breast cancer cells to radiation by inhibiting multiple kinases and inducing DNA damage
- (2020) Meghna Mehta et al. INTERNATIONAL JOURNAL OF RADIATION BIOLOGY
- Discovery of a Novel Dual-Target Inhibitor of ERK1 and ERK5 That Induces Regulated Cell Death to Overcome Compensatory Mechanism in Specific Tumor Types
- (2020) Guan Wang et al. JOURNAL OF MEDICINAL CHEMISTRY
- BRCAness, SLFN11, and RB1 loss predict response to topoisomerase I inhibitors in triple-negative breast cancers
- (2020) Florence Coussy et al. Science Translational Medicine
- Retraction: UM-164: A Potent c-Src/p38 Kinase Inhibitor with In Vivo Activity against Triple-Negative Breast Cancer
- (2020) Rabia A. Gilani et al. CLINICAL CANCER RESEARCH
- Inhibiting fatty acid synthase in operable triple negative breast cancer.
- (2020) Sagar D. Sardesai et al. JOURNAL OF CLINICAL ONCOLOGY
- RON and MET Co-overexpression Are Significant Pathological Characteristics of Poor Survival and Therapeutic Targets of Tyrosine Kinase Inhibitors in Triple-Negative Breast Cancer
- (2020) Tian-Hao Weng et al. Cancer Research and Treatment
- Molecular subtyping and genomic profiling expand precision medicine in refractory metastatic triple-negative breast cancer: the FUTURE trial
- (2020) Yi-Zhou Jiang et al. CELL RESEARCH
- SGCE Promotes Breast Cancer Stem Cells by Stabilizing EGFR
- (2020) Lina Zhao et al. Advanced Science
- Unraveling the Genomic-Epigenomic Interaction Landscape in Triple Negative and Non-Triple Negative Breast Cancer
- (2020) Jiande Wu et al. Cancers
- Molecular Features of Metaplastic Breast Carcinoma: An Infrequent Subtype of Triple Negative Breast Carcinoma
- (2020) Silvia González-Martínez et al. Cancers
- Cancer statistics, 2019
- (2019) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Interaction of EZH2 and P65 is involved in the arsenic trioxide-induced anti-angiogenesis in human triple-negative breast cancer cells
- (2019) Fei Jiang et al. CELL BIOLOGY AND TOXICOLOGY
- Targeting SET to restore PP2A activity disrupts an oncogenic CIP2A-feedforward loop and impairs triple negative breast cancer progression
- (2019) Chun-Yu Liu et al. EBioMedicine
- Varlitinib Downregulates HER/ERK Signaling and Induces Apoptosis in Triple Negative Breast Cancer Cells
- (2019) Chun-Yu Liu et al. Cancers
- Plasminogen activator inhibitor 1 (PAI1) promotes actin cytoskeleton reorganization and glycolytic metabolism in triple negative breast cancer
- (2019) Brock A Humphries et al. MOLECULAR CANCER RESEARCH
- Blockade of PDGFRβ circumvents resistance to MEK-JAK inhibition via intratumoral CD8+ T-cells infiltration in triple-negative breast cancer
- (2019) Murugan Kalimutho et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Anti-tumor and anti-metastasis efficacy of E6201, a MEK1 inhibitor, in preclinical models of triple-negative breast cancer
- (2019) Jangsoon Lee et al. BREAST CANCER RESEARCH AND TREATMENT
- New Drug Approvals in 2018 – Another Record Year!
- (2019) Alex M Ebied et al. AMERICAN JOURNAL OF MEDICINE
- C-terminal HSP90 inhibitor L80 elicits anti-metastatic effects in triple-negative breast cancer via STAT3 inhibition
- (2019) Tae-Min Cho et al. CANCER LETTERS
- Combined bazedoxifene and paclitaxel treatments inhibit cell viability, cell migration, colony formation, and tumor growth and induce apoptosis in breast cancer
- (2019) Shengling Fu et al. CANCER LETTERS
- Dual inhibition of Akt and ERK signaling induces cell senescence in triple-negative breast cancer
- (2019) Qiang He et al. CANCER LETTERS
- GSK2801, A BAZ2/BRD9 Bromodomain Inhibitor, Synergizes with BET Inhibitors to Induce Apoptosis in Triple-Negative Breast Cancer
- (2019) Samantha M. Bevill et al. MOLECULAR CANCER RESEARCH
- Acquired short QT syndrome in a cancer patient treated with Toad
- (2019) Yan Huang et al. PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY
- Apatinib enhanced anti-tumor activity of cisplatin on triple-negative breast cancer through inhibition of VEGFR-2
- (2019) Zhenyuan Gao et al. PATHOLOGY RESEARCH AND PRACTICE
- A novel UCHL3 inhibitor, perifosine, enhances PARP inhibitor cytotoxicity through inhibition of homologous recombination-mediated DNA double strand break repair
- (2019) Zhiwang Song et al. Cell Death & Disease
- PARP Inhibitor Efficacy Depends on CD8+ T-cell Recruitment via Intratumoral STING Pathway Activation in BRCA-Deficient Models of Triple-Negative Breast Cancer
- (2019) Constantia Pantelidou et al. Cancer Discovery
- Protein arginine methyltransferase 5: A novel therapeutic target for triple‐negative breast cancers
- (2019) Mathilde Vinet et al. Cancer Medicine
- A novel small-molecule antagonizes PRMT5-mediated KLF4 methylation for targeted therapy
- (2019) Zhuan Zhou et al. EBioMedicine
- TRPC3 Regulates the Proliferation and Apoptosis Resistance of Triple Negative Breast Cancer Cells through the TRPC3/RASA4/MAPK Pathway
- (2019) Wang et al. Cancers
- Co-Targeting Bulk Tumor and CSCs in Clinically Translatable TNBC Patient-Derived Xenografts via Combination Nanotherapy
- (2019) Andrew Sulaiman et al. MOLECULAR CANCER THERAPEUTICS
- Phenothiazine antipsychotics exhibit dual properties in pseudo-allergic reactions: Activating MRGPRX2 and inhibiting the H1 receptor
- (2019) Yajing Hou et al. MOLECULAR IMMUNOLOGY
- Death effector domain-containing protein induces vulnerability to cell cycle inhibition in triple-negative breast cancer
- (2019) Yingjia Ni et al. Nature Communications
- Cowpea Mosaic Virus Immunotherapy Combined with Cyclophosphamide Reduces Breast Cancer Tumor Burden and Inhibits Lung Metastasis
- (2019) Hui Cai et al. Advanced Science
- A Novel Role for Cathepsin S as a Potential Biomarker in Triple Negative Breast Cancer
- (2019) Richard D. A. Wilkinson et al. Journal of Oncology
- A Sesquiterpenoid from Farfarae Flos Induces Apoptosis of MDA-MB-231 Human Breast Cancer Cells through Inhibition of JAK–STAT3 Signaling
- (2019) Hyeri Jang et al. Biomolecules
- Multi-targeted kinase inhibition alleviates mTOR inhibitor resistance in triple-negative breast cancer
- (2019) Jichao He et al. BREAST CANCER RESEARCH AND TREATMENT
- PI3K/AKT/mTOR pathway inhibitors in triple-negative breast cancer: a review on drug discovery and future challenges
- (2019) Mohammad A. Khan et al. DRUG DISCOVERY TODAY
- JQ1-Loaded Polydopamine Nanoplatform Inhibits c-MYC/Programmed Cell Death Ligand 1 to Enhance Photothermal Therapy for Triple-Negative Breast Cancer
- (2019) Ying Tian et al. ACS Applied Materials & Interfaces
- Targeted Therapies for Triple-Negative Breast Cancer
- (2019) Tomas G. Lyons CURRENT TREATMENT OPTIONS IN ONCOLOGY
- Combined MEK inhibition and tumor-associated macrophages depletion suppresses tumor growth in a triple-negative breast cancer mouse model
- (2019) Qiulei Zhang et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Inhibition of dual-specificity tyrosine phosphorylation-regulated kinase 2 perturbs 26S proteasome-addicted neoplastic progression
- (2019) Sourav Banerjee et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- CDK2-mediated site-specific phosphorylation of EZH2 drives and maintains triple-negative breast cancer
- (2019) Lei Nie et al. Nature Communications
- Anti-tumor activity of BET inhibitors in androgen-receptor-expressing triple-negative breast cancer
- (2019) In Hae Park et al. Scientific Reports
- An increased cell cycle gene network determines MEK and Akt inhibitor double resistance in triple-negative breast cancer
- (2019) Vera E. van der Noord et al. Scientific Reports
- Targeting autophagy-related protein kinases for potential therapeutic purpose
- (2019) Honggang Xiang et al. Acta Pharmaceutica Sinica B
- 1,3-Dicaffeoylquinic acid targeting 14-3-3 tau suppresses human breast cancer cell proliferation and metastasis through IL6/JAK2/PI3K pathway
- (2019) Yuhang Zhou et al. BIOCHEMICAL PHARMACOLOGY
- Marine natural compound cyclo(L-leucyl-L-prolyl) peptide inhibits migration of triple negative breast cancer cells by disrupting interaction of CD151 and EGFR signaling
- (2019) Deepak KGK et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Capivasertib Plus Paclitaxel Versus Placebo Plus Paclitaxel As First-Line Therapy for Metastatic Triple-Negative Breast Cancer: The PAKT Trial
- (2019) Peter Schmid et al. JOURNAL OF CLINICAL ONCOLOGY
- Torin2 Exploits Replication and Checkpoint Vulnerabilities to Cause Death of PI3K-Activated Triple-Negative Breast Cancer Cells
- (2019) Sameer S. Chopra et al. Cell Systems
- Unravelling triple-negative breast cancer molecular heterogeneity using an integrative multiomic analysis
- (2018) Y Bareche et al. ANNALS OF ONCOLOGY
- Isoharringtonine inhibits breast cancer stem-like properties and STAT3 signaling
- (2018) Wei Chen et al. BIOMEDICINE & PHARMACOTHERAPY
- Overexpression of miR-361-5p in triple-negative breast cancer (TNBC) inhibits migration and invasion by targeting RQCD1 and inhibiting the EGFR/ PI3K/Akt pathway
- (2018) Jianjun Han et al. Bosnian Journal of Basic Medical Sciences
- Thymoquinone inhibits cell proliferation, migration, and invasion by regulating the elongation factor 2 kinase (eEF-2K) signaling axis in triple-negative breast cancer
- (2018) Nashwa Kabil et al. BREAST CANCER RESEARCH AND TREATMENT
- Reciprocal Regulation of DUSP9 and DUSP16 Expression by HIF-1 Controls ERK and p38 MAP Kinase Activity and Mediates Chemotherapy-Induced Breast Cancer Stem Cell Enrichment
- (2018) Haiquan Lu et al. CANCER RESEARCH
- Triple negative breast cancer: Emerging therapeutic modalities and novel combination therapies
- (2018) Alice Lee et al. CANCER TREATMENT REVIEWS
- Design, synthesis and structure-activity relationship of a focused library of β-phenylalanine derivatives as novel eEF2K inhibitors with apoptosis-inducing mechanisms in breast cancer
- (2018) Yongzhi Guo et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Flubendazole elicits anti-metastatic effects in triple-negative breast cancer via STAT3 inhibition
- (2018) Eunhye Oh et al. INTERNATIONAL JOURNAL OF CANCER
- Salidroside inhibits migration, invasion and angiogenesis of MDA‑MB�231 TNBC cells by regulating EGFR/Jak2/STAT3 signaling via MMP2
- (2018) Dong Young Kang et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Enzalutamide for the Treatment of Androgen Receptor–Expressing Triple-Negative Breast Cancer
- (2018) Tiffany A. Traina et al. JOURNAL OF CLINICAL ONCOLOGY
- The anti-tumor efficacy of CDK4/6 inhibition is enhanced by the combination with PI3K/AKT/mTOR inhibitors through impairment of glucose metabolism in TNBC cells
- (2018) Daniele Cretella et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- 131 -Oxophorbine protopheophorbide A from Ziziphus lotus as a novel mesenchymal-epithelial transition factor receptor inhibitory lead for the control of breast tumor growth in vitro and in vivo
- (2018) Soumaya Souid et al. MOLECULAR CARCINOGENESIS
- Combinatorial inhibition of PTPN12-regulated receptors leads to a broadly effective therapeutic strategy in triple-negative breast cancer
- (2018) Amritha Nair et al. NATURE MEDICINE
- Activation of STAT3 and Bcl-2 and reduction of reactive oxygen species (ROS) promote radioresistance in breast cancer and overcome of radioresistance with niclosamide
- (2018) Lu Lu et al. ONCOGENE
- AR negative triple negative or “quadruple negative” breast cancers in African American women have an enriched basal and immune signature
- (2018) Melissa Davis et al. PLoS One
- Spatially constrained tandem bromodomain inhibition bolsters sustained repression of BRD4 transcriptional activity for TNBC cell growth
- (2018) Chunyan Ren et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Lysine methyltransferase SMYD2 promotes triple negative breast cancer progression
- (2018) Linda Xiaoyan Li et al. Cell Death & Disease
- Narciclasine induces autophagy-dependent apoptosis in triple-negative breast cancer cells by regulating the AMPK-ULK1 axis
- (2018) Chuan Cao et al. CELL PROLIFERATION
- BET proteins regulate homologous recombination-mediated DNA repair: BRCAness and implications for cancer therapy
- (2018) C. Mio et al. INTERNATIONAL JOURNAL OF CANCER
- Paclitaxel With Inhibitor of Apoptosis Antagonist, LCL161, for Localized Triple-Negative Breast Cancer, Prospectively Stratified by Gene Signature in a Biomarker-Driven Neoadjuvant Trial
- (2018) Aditya Bardia et al. JOURNAL OF CLINICAL ONCOLOGY
- Neoadjuvant talazoparib (TALA) for operable breast cancer patients with a BRCA mutation (BRCA+).
- (2018) Jennifer Keating Litton et al. JOURNAL OF CLINICAL ONCOLOGY
- An open label, pilot study of veliparib (ABT-888) and lapatinib in patients with metastatic, triple negative (ER, PR, and HER-2 negative) breast cancer.
- (2018) Erica Michelle Stringer-Reasor et al. JOURNAL OF CLINICAL ONCOLOGY
- Pseudopterosin Inhibits Proliferation and 3D Invasion in Triple-Negative Breast Cancer by Agonizing Glucocorticoid Receptor Alpha
- (2018) Julia Sperlich et al. MOLECULES
- Comparative Effectiveness of an mTOR‐Based Systemic Therapy Regimen in Advanced, Metaplastic and Nonmetaplastic Triple‐Negative Breast Cancer
- (2018) Reva K. Basho et al. ONCOLOGIST
- Berberine down-regulates IL-8 expression through inhibition of the EGFR/MEK/ERK pathway in triple-negative breast cancer cells
- (2018) Sangmin Kim et al. PHYTOMEDICINE
- Combination of EGFR Inhibitor Lapatinib and MET Inhibitor Foretinib Inhibits Migration of Triple Negative Breast Cancer Cell Lines
- (2018) Aleksandra Simiczyjew et al. Cancers
- Dasatinib sensitises triple negative breast cancer cells to chemotherapy by targeting breast cancer stem cells
- (2018) Jun Tian et al. BRITISH JOURNAL OF CANCER
- Signaling pathway inhibitors target breast cancer stem cells in triple-negative breast cancer
- (2018) Wenlong Li et al. ONCOLOGY REPORTS
- The clinical promise of immunotherapy in triple-negative breast cancer
- (2018) Praveen Vikas et al. Cancer Management and Research
- Design, synthesis and structure-activity relationship studies of a focused library of pyrimidine moiety with anti-proliferative and anti-metastasis activities in triple negative breast cancer
- (2017) Dahong Yao et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Integrated bioinformatics, computational and experimental methods to discover novel Raf/extracellular-signal regulated kinase (ERK) dual inhibitors against breast cancer cells
- (2017) Yin Chen et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Targeting HSP90-HDAC6 Regulating Network Implicates Precision Treatment of Breast Cancer
- (2017) Shiyi Yu et al. International Journal of Biological Sciences
- Discovery of a Small-Molecule Bromodomain-Containing Protein 4 (BRD4) Inhibitor That Induces AMP-Activated Protein Kinase-Modulated Autophagy-Associated Cell Death in Breast Cancer
- (2017) Liang Ouyang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Survival outcomes of neoadjuvant chemotherapy with zoledronic acid for HER2-negative breast cancer
- (2017) Takashi Ishikawa et al. JOURNAL OF SURGICAL RESEARCH
- Ipatasertib plus paclitaxel versus placebo plus paclitaxel as first-line therapy for metastatic triple-negative breast cancer (LOTUS): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial
- (2017) Sung-Bae Kim et al. LANCET ONCOLOGY
- PIM1: a promising target in patients with triple-negative breast cancer
- (2017) Wen Zhao et al. MEDICAL ONCOLOGY
- Integrating multiple omics data for the discovery of potential Beclin-1 interactions in breast cancer
- (2017) Yi Chen et al. Molecular BioSystems
- ONC201 Demonstrates Antitumor Effects in Both Triple-Negative and Non–Triple-Negative Breast Cancers through TRAIL-Dependent and TRAIL-Independent Mechanisms
- (2017) Marie D. Ralff et al. MOLECULAR CANCER THERAPEUTICS
- Sorafenib analogue SC-60 induces apoptosis through the SHP-1/STAT3 pathway and enhances docetaxel cytotoxicity in triple-negative breast cancer cells
- (2017) Chun-Yu Liu et al. Molecular Oncology
- Precise discovery of a STAT3 inhibitor from Eupatorium lindleyanum and evaluation of its activity of anti-triple-negative breast cancer
- (2017) Bo Yang et al. NATURAL PRODUCT RESEARCH
- Combined kinase inhibitors of MEK1/2 and either PI3K or PDGFR are efficacious in intracranial triple-negative breast cancer
- (2017) Amanda E D Van Swearingen et al. NEURO-ONCOLOGY
- Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation
- (2017) Mark Robson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Coexpression of NOS2 and COX2 accelerates tumor growth and reduces survival in estrogen receptor-negative breast cancer
- (2017) Debashree Basudhar et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Synergistic action of the MCL-1 inhibitor S63845 with current therapies in preclinical models of triple-negative and HER2-amplified breast cancer
- (2017) Delphine Merino et al. Science Translational Medicine
- Discovery of a small molecule targeting ULK1-modulated cell death of triple negative breast cancer in vitro and in vivo
- (2017) Lan Zhang et al. Chemical Science
- Enhancer Remodeling during Adaptive Bypass to MEK Inhibition Is Attenuated by Pharmacologic Targeting of the P-TEFb Complex
- (2017) Jon S. Zawistowski et al. Cancer Discovery
- Identifying and Targeting Sporadic Oncogenic Genetic Aberrations in Mouse Models of Triple-Negative Breast Cancer
- (2017) Hui Liu et al. Cancer Discovery
- Inhibition of HSP90 sensitizes a novel Raf/ERK dual inhibitor CY-9d in triple-negative breast cancer cells
- (2017) Yujuan Chen et al. Oncotarget
- Targeting the PI3K/AKT/mTOR Pathway for the Treatment of Mesenchymal Triple-Negative Breast Cancer
- (2017) Reva K. Basho et al. JAMA Oncology
- Dasatinib inhibits c-src phosphorylation and prevents the proliferation of Triple-Negative Breast Cancer (TNBC) cells which overexpress Syndecan-Binding Protein (SDCBP)
- (2017) Xiao-Long Qian et al. PLoS One
- Characterization of HJ-PI01 as a novel Pim-2 inhibitor that induces apoptosis and autophagic cell death in triple-negative human breast cancer
- (2016) Yu-qian Zhao et al. ACTA PHARMACOLOGICA SINICA
- An overview of the effective combination therapies for the treatment of breast cancer
- (2016) Cristina Núñez et al. BIOMATERIALS
- Canadian Cancer Trials Group IND197: a phase II study of foretinib in patients with estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2-negative recurrent or metastatic breast cancer
- (2016) Daniel Rayson et al. BREAST CANCER RESEARCH AND TREATMENT
- PRL-3 engages the focal adhesion pathway in triple-negative breast cancer cells to alter actin structure and substrate adhesion properties critical for cell migration and invasion
- (2016) Hamid H. Gari et al. CANCER LETTERS
- Targeting of PYK2 Synergizes with EGFR Antagonists in Basal-like TNBC and Circumvents HER3-Associated Resistance via the NEDD4–NDRG1 Axis
- (2016) Nandini Verma et al. CANCER RESEARCH
- BRD4 Regulates Breast Cancer Dissemination through Jagged1/Notch1 Signaling
- (2016) Guillaume Andrieu et al. CANCER RESEARCH
- Vandetanib as a potential new treatment for estrogen receptor-negative breast cancers
- (2016) Rana Hatem et al. INTERNATIONAL JOURNAL OF CANCER
- From Lead to Drug Candidate: Optimization of 3-(Phenylethynyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine Derivatives as Agents for the Treatment of Triple Negative Breast Cancer
- (2016) Chun-Hui Zhang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Targeting a Cancer-Specific Epitope of the Epidermal Growth Factor Receptor in Triple-Negative Breast Cancer
- (2016) Nathan Simon et al. JNCI-Journal of the National Cancer Institute
- Targeting Programmed Cell Death Using Small-Molecule Compounds to Improve Potential Cancer Therapy
- (2016) Bowen Ke et al. MEDICINAL RESEARCH REVIEWS
- Integrative bioinformatics and proteomics-based discovery of an eEF2K inhibitor (cefatrizine) with ER stress modulation in breast cancer cells
- (2016) Zhiqiang Yao et al. Molecular BioSystems
- Systematic network-based discovery of a Fam20C inhibitor (FL-1607) with apoptosis modulation in triple-negative breast cancer
- (2016) Ziyi Qin et al. Molecular BioSystems
- Combination of the novel histone deacetylase inhibitor YCW1 and radiation induces autophagic cell death through the downregulation of BNIP3 in triple-negative breast cancer cells in vitro and in an orthotopic mouse model
- (2016) Hui-Wen Chiu et al. Molecular Cancer
- Identification of selective cytotoxic and synthetic lethal drug responses in triple negative breast cancer cells
- (2016) Prson Gautam et al. Molecular Cancer
- Development of a RSK Inhibitor as a Novel Therapy for Triple-Negative Breast Cancer
- (2016) K. A. Ludwik et al. MOLECULAR CANCER THERAPEUTICS
- Response and resistance to BET bromodomain inhibitors in triple-negative breast cancer
- (2016) Shaokun Shu et al. NATURE
- SPRY1 regulates mammary epithelial morphogenesis by modulating EGFR-dependent stromal paracrine signaling and ECM remodeling
- (2016) Zuzana Koledova et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- IL-17E synergizes with EGF and confers in vitro resistance to EGFR-targeted therapies in TNBC cells
- (2016) Yacine Merrouche et al. Oncotarget
- Androgen receptor expression predicts different clinical outcomes for breast cancer patients stratified by hormone receptor status
- (2016) He-Sheng Jiang et al. Oncotarget
- Targeting MET and EGFR crosstalk signaling in triple-negative breast cancers
- (2016) Erik S. Linklater et al. Oncotarget
- Anti-EGFR monoclonal antibodies and EGFR tyrosine kinase inhibitors as combination therapy for triple-negative breast cancer
- (2016) Abderrahim El Guerrab et al. Oncotarget
- MicroRNA 603 acts as a tumor suppressor and inhibits triple-negative breast cancer tumorigenesis by targeting elongation factor 2 kinase
- (2016) Recep Bayraktar et al. Oncotarget
- Crystal structure-based discovery of a novel synthesized PARP1 inhibitor (OL-1) with apoptosis-inducing mechanisms in triple-negative breast cancer
- (2016) Leilei Fu et al. Scientific Reports
- CDK12 Inhibition Reverses De Novo and Acquired PARP Inhibitor Resistance in BRCA Wild-Type and Mutated Models of Triple-Negative Breast Cancer
- (2016) Shawn F. Johnson et al. Cell Reports
- Targeting a Cancer-Specific Epitope of the Epidermal Growth Factor Receptor in Triple-Negative Breast Cancer
- (2016) Nathan Simon et al. JNCI-Journal of the National Cancer Institute
- Anticancer Effects of the Hsp90 Inhibitor 17-Demethoxy-Reblastatin in Human Breast Cancer MDA-MB-231 Cells
- (2016) Qing Zhao et al. JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY
- Refinement of Triple-Negative Breast Cancer Molecular Subtypes: Implications for Neoadjuvant Chemotherapy Selection
- (2016) Brian D. Lehmann et al. PLoS One
- Inhibition of the phosphoinositide 3-kinase pathway for the treatment of patients with metastatic metaplastic breast cancer
- (2015) S. Moulder et al. ANNALS OF ONCOLOGY
- Inhibition of the spindle assembly checkpoint kinase TTK enhances the efficacy of docetaxel in a triple-negative breast cancer model
- (2015) A. R. R. Maia et al. ANNALS OF ONCOLOGY
- Dual treatments targeting IGF-1R, PI3K, mTORC or MEK synergize to inhibit cell growth, induce apoptosis, and arrest cell cycle at G1 phase in MDA-MB-231 cell line
- (2015) Ayunadirah Ayub et al. BIOMEDICINE & PHARMACOTHERAPY
- Alantolactone selectively suppresses STAT3 activation and exhibits potent anticancer activity in MDA-MB-231 cells
- (2015) Jaemoo Chun et al. CANCER LETTERS
- Src/STAT3-dependent heme oxygenase-1 induction mediates chemoresistance of breast cancer cells to doxorubicin by promoting autophagy
- (2015) Qixing Tan et al. CANCER SCIENCE
- mTOR Inhibitors Suppress Homologous Recombination Repair and Synergize with PARP Inhibitors via Regulating SUV39H1 in BRCA-Proficient Triple-Negative Breast Cancer
- (2015) W. Mo et al. CLINICAL CANCER RESEARCH
- RAS/MAPK Activation Is Associated with Reduced Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer: Therapeutic Cooperation Between MEK and PD-1/PD-L1 Immune Checkpoint Inhibitors
- (2015) S. Loi et al. CLINICAL CANCER RESEARCH
- 1977 Synergy of LCL161, an antagonist of inhibitor of apoptosis proteins (IAPs), with paclitaxel in a gene expression signature-enriched cohort of triple-negative breast cancer (TNBC)
- (2015) A. Bardia et al. EUROPEAN JOURNAL OF CANCER
- Inherited Mutations in 17 Breast Cancer Susceptibility Genes Among a Large Triple-Negative Breast Cancer Cohort Unselected for Family History of Breast Cancer
- (2015) Fergus J. Couch et al. JOURNAL OF CLINICAL ONCOLOGY
- Design, Synthesis, and Structure–Activity Relationship Studies of 3-(Phenylethynyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine Derivatives as a New Class of Src Inhibitors with Potent Activities in Models of Triple Negative Breast Cancer
- (2015) Chun-Hui Zhang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Systems biology-based discovery of a potential Atg4B agonist (Flubendazole) that induces autophagy in breast cancer
- (2015) Lan Zhang et al. Molecular BioSystems
- Preclinical Evaluation of a Novel Orally Available SRC/Raf/VEGFR2 Inhibitor, SKLB646, in the Treatment of Triple-Negative Breast Cancer
- (2015) M.-W. Zheng et al. MOLECULAR CANCER THERAPEUTICS
- Antitumor Activity of KW-2450 against Triple-Negative Breast Cancer by Inhibiting Aurora A and B Kinases
- (2015) K. Kai et al. MOLECULAR CANCER THERAPEUTICS
- Histone Deacetylase Inhibitor Entinostat Inhibits Tumor-Initiating Cells in Triple-Negative Breast Cancer Cells
- (2015) A. Schech et al. MOLECULAR CANCER THERAPEUTICS
- Modulation of the tumor microenvironment and inhibition of EGF/EGFR pathway: Novel anti-tumor mechanisms of Cannabidiol in breast cancer
- (2015) Mohamad Elbaz et al. Molecular Oncology
- Robust enumeration of cell subsets from tissue expression profiles
- (2015) Aaron M Newman et al. NATURE METHODS
- Computational design, chemical synthesis, and biological evaluation of a novel ERK inhibitor (BL-EI001) with apoptosis-inducing mechanisms in breast cancer
- (2015) Bo Liu et al. Oncotarget
- Comprehensive Two- and Three-Dimensional RNAi Screening Identifies PI3K Inhibition as a Complement to MEK Inhibitor AS703026 for Combination Treatment of Triple-Negative Breast Cancer
- (2015) Jangsoon Lee et al. Journal of Cancer
- Salinomycin Promotes Anoikis and Decreases the CD44+/CD24- Stem-Like Population via Inhibition of STAT3 Activation in MDA-MB-231 Cells
- (2015) Hyunsook An et al. PLoS One
- Randomized Controlled Trial of Zoledronic Acid plus Chemotherapy versus Chemotherapy Alone as Neoadjuvant Treatment of HER2-Negative Primary Breast Cancer (JONIE Study)
- (2015) Yoshie Hasegawa et al. PLoS One
- Open-label randomized clinical trial of standard neoadjuvant chemotherapy with paclitaxel followed by FEC versus the combination of paclitaxel and everolimus followed by FEC in women with triple receptor-negative breast cancer†
- (2014) A. M. Gonzalez-Angulo et al. ANNALS OF ONCOLOGY
- The aryl hydrocarbon receptor ligand omeprazole inhibits breast cancer cell invasion and metastasis
- (2014) Un-Ho Jin et al. BMC CANCER
- Eukaryotic elongation factor 2 kinase confers tolerance to stress conditions in cancer cells
- (2014) Hongcheng Zhu et al. CELL STRESS & CHAPERONES
- Combined deletion of Pten and p53 in mammary epithelium accelerates triple-negative breast cancer with dependency on eEF2K
- (2014) J. C. Liu et al. EMBO Molecular Medicine
- Extrapyramidal symptoms following administration of oral perphenazine 4 or 8 mg
- (2014) John P. Henao et al. EUROPEAN JOURNAL OF ANAESTHESIOLOGY
- Cross-talk between Endoplasmic Reticulum (ER) Stress and the MEK/ERK Pathway Potentiates Apoptosis in Human Triple Negative Breast Carcinoma Cells
- (2014) Swatilekha Ghosh et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Targeting an IKBKE cytokine network impairs triple-negative breast cancer growth
- (2014) Thanh U. Barbie et al. JOURNAL OF CLINICAL INVESTIGATION
- VEGF drives cancer-initiating stem cells through VEGFR-2/Stat3 signaling to upregulate Myc and Sox2
- (2014) D Zhao et al. ONCOGENE
- The Potent Cdc7-Dbf4 (DDK) Kinase Inhibitor XL413 Has Limited Activity in Many Cancer Cell Lines and Discovery of Potential New DDK Inhibitor Scaffolds
- (2014) Nanda Kumar Sasi et al. PLoS One
- Simvastatin Radiosensitizes Differentiated and Stem-Like Breast Cancer Cell Lines and Is Associated With Improved Local Control in Inflammatory Breast Cancer Patients Treated With Postmastectomy Radiation
- (2014) Lara Lacerda et al. Stem Cells Translational Medicine
- Therapeutic effect of β-blockers in triple-negative breast cancer postmenopausal women
- (2013) Edoardo Botteri et al. BREAST CANCER RESEARCH AND TREATMENT
- Prognostic and Predictive Value of Tumor Vascular Endothelial Growth Factor Gene Amplification in Metastatic Breast Cancer Treated with Paclitaxel with and without Bevacizumab; Results from ECOG 2100 Trial
- (2013) B. P. Schneider et al. CLINICAL CANCER RESEARCH
- TGF-β inhibition enhances chemotherapy action against triple-negative breast cancer
- (2013) Neil E. Bhola et al. JOURNAL OF CLINICAL INVESTIGATION
- Reactivation of Estrogen Receptor α by Vorinostat Sensitizes Mesenchymal-Like Triple-Negative Breast Cancer to Aminoflavone, a Ligand of the Aryl Hydrocarbon Receptor
- (2013) Karri Stark et al. PLoS One
- Inhibition of triple-negative breast cancer models by combinations of antibodies to EGFR
- (2013) D. A. Ferraro et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Prognostic value of survivin and EGFR protein expression in triple-negative breast cancer (TNBC) patients
- (2013) Minghui Zhang et al. Targeted Oncology
- Genome and Transcriptome Sequencing in Prospective Metastatic Triple-Negative Breast Cancer Uncovers Therapeutic Vulnerabilities
- (2012) D. W. Craig et al. MOLECULAR CANCER THERAPEUTICS
- High ERK Protein Expression Levels Correlate with Shorter Survival in Triple-Negative Breast Cancer Patients
- (2012) C. Bartholomeusz et al. ONCOLOGIST
- Effect of metformin on survival outcomes in diabetic patients with triple receptor-negative breast cancer
- (2011) Soley Bayraktar et al. CANCER
- Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
- (2011) Brian D. Lehmann et al. JOURNAL OF CLINICAL INVESTIGATION
- The JAK2/STAT3 signaling pathway is required for growth of CD44+CD24– stem cell–like breast cancer cells in human tumors
- (2011) Lauren L.C. Marotta et al. JOURNAL OF CLINICAL INVESTIGATION
- Beta-Blocker Use Is Associated With Improved Relapse-Free Survival in Patients With Triple-Negative Breast Cancer
- (2011) Amal Melhem-Bertrandt et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic value of androgen receptor expression in operable triple-negative breast cancer: a retrospective analysis based on a tissue microarray
- (2011) Jiehua He et al. MEDICAL ONCOLOGY
- A multicenter randomized phase II study of sequential epirubicin/cyclophosphamide followed by docetaxel with or without celecoxib or trastuzumab according to HER2 status, as primary chemotherapy for localized invasive breast cancer patients
- (2010) Jean-Yves Pierga et al. BREAST CANCER RESEARCH AND TREATMENT
- Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial
- (2010) M William Audeh et al. LANCET
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started